{
    "nct_id": "NCT06815432",
    "official_title": "GPC-3 Chimeric Antigen Receptor T Cells for Recurrent GPC-3 Positive Glioblastoma",
    "inclusion_criteria": "* GPC3-positive* recurrent GBM with previous resection (as determined by immunohistochemistry with an extent score of >=Grade 2 [>25% positive tumor cells] and an intensity score of >= 2 [scale 0-4]).\n* Age ≥18 years\n* Karnofsky score ≥60%\n* Informed consent explained to, understood by and signed by patient/guardian. Patient/guardian given copy of informed consent\n\nProcurement\nHealthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* History of hypersensitivity reactions to murine protein-containing products OR presence of human anti-mouse antibody (HAMA) prior to enrollment (only patients who have received prior therapy with murine antibodies).\n* History of organ transplantation\n* Known HIV positivity\n* Active bacterial, fungal or viral infection (except Hepatitis B or Hepatitis C virus infections).\n\nTreatment Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of recurrent glioblastoma with previous resection\n* Karnofsky score ≥ 60%-\n* Stable neurologic exam for 7 days prior to enrollment\n* Stable or decreasing dose of steroids over past 7 days prior to surgery and administration of therapy (max allowable dose is 0.1mg/kg dexamethasone or equivalent per day)\n* Adequate organ function:\n* Creatinine clearance as estimated by Cockcroft Gault or Schwartz ≥ 60 ml/min\n* total bilirubin < 3 times ULN for age\n* INR ≤1.7\n* absolute neutrophil count > 500/μl\n* platelet count > 100,000/μl (can be transfused but must be achieved prior to enrollment)\n* Hgb ≥ 7.0 g/dl (can be transfused)\n* Pulse oximetry >90% on room air\n* Recovered from acute toxic effects of all prior chemotherapy and investigational agents before entering this study\n* Sexually active patients must be willing to utilize one of the more effective birth control methods for 3 months after the T-cell infusion.\n* Informed consent explained to, understood by and signed by patient/guardian. Patient/guardian given copy of informed consent.\n\nTreatment Exclusion Criteria:\n\n* Pregnancy or lactation\n* Uncontrolled infection\n* Known HIV positivity\n* Active bacterial, fungal or viral infection\n* History of organ transplantation\n* History of hypersensitivity reactions to murine protein-containing products OR presence of human anti-mouse antibody (HAMA) prior to enrollment (only patients who have received prior therapy with murine antibodies)",
    "miscellaneous_criteria": "Procurement"
}